Yale Updates on GBM & Meningioma: Are We Seeing Increased Survival Rates With TMZ + RT, Bevacizumab & New Optune Device Treatment? What Are the Meningioma Treatment Modalities?
By
Yale Cancer Center
FEATURING
Nicholas Blondin
By
Yale Cancer Center
FEATURING
Nicholas Blondin
Login to view comments.
Click here to Login
